Company intelligence / Profile preview

Healthasion

Ownership: Private
Development stage: Other

Overview

Healthasion is not a therapeutics developer but provides expertise and infrastructure to enable global collaborations in personalized healthcare, genomics, bioinformatics, molecular biology, rare diseases, rehabilitation medicine, and related fields. Its leadership includes internationally recognized experts from academia and industry with backgrounds in genetics research (e.g., type 2 diabetes loci), genome sequencing/interpretation for clinical use, special needs/rare disease care delivery. No clinical trial results are reported.

Industry: Consulting

Partnerships

Focuses on enabling partnerships between startups/institutions globally; no named major pharma/biotech partners listed publicly

Beyond the preview

Go deeper on Healthasion.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Healthasion.

Explore the full profile